待处理
入排:排除
图源:待检查
Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette-Guérin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle-invasive bladder cancer (NMIBC). Ann Oncol. In press. https://doi.org/10.1016/j.annonc.2025.09.017.
David D'Andrea, Shahrokh F Shariat
Eur Urol Oncol 9(1) 203-204
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板